Neurodegenerative Diseases

Neurodegenerative Diseases


  • Neurodegenerative Diseases
  • Focus on personalized solutions for unmet medical needs

    Merck Serono has a long-term commitment to developing innovative treatments to help manage neurodegenerative diseases such as multiple sclerosis (MS).

    As part of this commitment, we strive to develop new treatment options and drug delivery devices as well as offering enhanced patient programs and support services. In addition to our leading interferon beta therapy, Rebif®, we currently have several projects in our R&D pipeline with the potential to offer new therapeutic options to patients with MS.

    Rebif®